Allmed Solutions Ltd
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers medical devices for the treatment of type 2 diabetes in obese and overweight patients; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any… Read more
Allmed Solutions Ltd (ALMD) - Net Assets
Latest net assets as of June 2025: ILA35.08 Million ILA
Based on the latest financial reports, Allmed Solutions Ltd (ALMD) has net assets worth ILA35.08 Million ILA as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA37.56 Million) and total liabilities (ILA2.48 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA35.08 Million |
| % of Total Assets | 93.38% |
| Annual Growth Rate | 7.02% |
| 5-Year Change | -13.85% |
| 10-Year Change | -6.89% |
| Growth Volatility | 59.92 |
Allmed Solutions Ltd - Net Assets Trend (2008–2024)
This chart illustrates how Allmed Solutions Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Allmed Solutions Ltd (2008–2024)
The table below shows the annual net assets of Allmed Solutions Ltd from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ILA42.02 Million | -24.93% |
| 2023-12-31 | ILA55.97 Million | +3.73% |
| 2022-12-31 | ILA53.96 Million | +3.15% |
| 2021-12-31 | ILA52.31 Million | +7.26% |
| 2020-12-31 | ILA48.77 Million | -13.80% |
| 2019-12-31 | ILA56.58 Million | +72.33% |
| 2018-12-31 | ILA32.83 Million | -15.28% |
| 2017-12-31 | ILA38.76 Million | +1.48% |
| 2016-12-31 | ILA38.19 Million | -15.37% |
| 2015-12-31 | ILA45.13 Million | +40.32% |
| 2014-12-31 | ILA32.16 Million | +6.41% |
| 2013-12-31 | ILA30.22 Million | -55.09% |
| 2012-12-31 | ILA67.29 Million | -7.00% |
| 2011-12-31 | ILA72.36 Million | +175.25% |
| 2010-12-31 | ILA26.29 Million | +142.70% |
| 2009-12-31 | ILA10.83 Million | -23.66% |
| 2008-12-31 | ILA14.19 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Allmed Solutions Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 22280200000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA19.22 Million | 48.90% |
| Other Comprehensive Income | ILA12.30 Million | 31.30% |
| Other Components | ILA243.88 Million | 620.44% |
| Total Equity | ILA39.31 Million | 100.00% |
Allmed Solutions Ltd Competitors by Market Cap
The table below lists competitors of Allmed Solutions Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
REMEGEN CO. LTD YC 1
F:REG
|
$96.68K |
|
Galata Acquisition Corp. II Class A Ordinary Shares
NASDAQ:LATA
|
$96.79K |
|
NAMPAK LTD RC-05
F:NNZA
|
$96.80K |
|
GAIA GROW CORP.
F:GG00
|
$96.82K |
|
Putnam Municipal Opportunities Trust
NYSE:PMO
|
$96.59K |
|
TERNA (UEI.SG)
STU:UEI
|
$96.57K |
|
Galaxy Ventures Inc.
V:GXY-P
|
$96.50K |
|
BLACKROCK ENH.GBL DIV.TR.
F:1JQ
|
$96.44K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Allmed Solutions Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 53,423,000 to 39,307,000, a change of -14,116,000 (-26.4%).
- Net loss of 8,752,000 reduced equity.
- Share repurchases of 5,494,000 reduced equity.
- Other comprehensive income decreased equity by 2,263,999.
- Other factors increased equity by 2,393,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-8.75 Million | -22.27% |
| Share Repurchases | ILA5.49 Million | -13.98% |
| Other Comprehensive Income | ILA-2.26 Million | -5.76% |
| Other Changes | ILA2.39 Million | +6.09% |
| Total Change | ILA- | -26.42% |
Book Value vs Market Value Analysis
This analysis compares Allmed Solutions Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 95111.77x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 4.99x to 95111.77x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | ILA7.56 | ILA37.70 | x |
| 2012-12-31 | ILA7.90 | ILA37.70 | x |
| 2013-12-31 | ILA3.05 | ILA37.70 | x |
| 2014-12-31 | ILA1.75 | ILA37.70 | x |
| 2015-12-31 | ILA1.58 | ILA37.70 | x |
| 2016-12-31 | ILA0.85 | ILA37.70 | x |
| 2017-12-31 | ILA0.66 | ILA37.70 | x |
| 2018-12-31 | ILA0.45 | ILA37.70 | x |
| 2019-12-31 | ILA0.72 | ILA37.70 | x |
| 2020-12-31 | ILA0.61 | ILA37.70 | x |
| 2021-12-31 | ILA0.63 | ILA37.70 | x |
| 2022-12-31 | ILA0.64 | ILA37.70 | x |
| 2023-12-31 | ILA0.66 | ILA37.70 | x |
| 2024-12-31 | ILA0.00 | ILA37.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Allmed Solutions Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -22.27%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.14x
- Recent ROE (-22.27%) is above the historical average (-39.21%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -44.58% | 0.00% | 0.00x | 1.09x | ILA-7.74 Million |
| 2009 | -35.78% | 0.00% | 0.00x | 1.06x | ILA-4.96 Million |
| 2010 | -35.72% | -1980.80% | 0.01x | 1.36x | ILA-12.02 Million |
| 2011 | -19.44% | -548.85% | 0.03x | 1.10x | ILA-21.30 Million |
| 2012 | -44.27% | -1116.04% | 0.03x | 1.20x | ILA-36.52 Million |
| 2013 | -165.46% | -1063.71% | 0.11x | 1.44x | ILA-53.03 Million |
| 2014 | -76.63% | -501.30% | 0.11x | 1.39x | ILA-27.86 Million |
| 2015 | -46.38% | -404.25% | 0.09x | 1.26x | ILA-25.44 Million |
| 2016 | -62.62% | -325.27% | 0.14x | 1.37x | ILA-27.74 Million |
| 2017 | -58.98% | -294.42% | 0.15x | 1.35x | ILA-26.52 Million |
| 2018 | -61.64% | -217.43% | 0.22x | 1.32x | ILA-23.45 Million |
| 2019 | 38.33% | 197.25% | 0.17x | 1.17x | ILA16.25 Million |
| 2020 | -17.70% | -89.08% | 0.17x | 1.15x | ILA-13.55 Million |
| 2021 | 5.57% | 50.64% | 0.10x | 1.09x | ILA-2.23 Million |
| 2022 | -21.73% | 0.00% | 0.00x | 1.12x | ILA-16.34 Million |
| 2023 | 2.66% | 0.00% | 0.00x | 1.11x | ILA-3.92 Million |
| 2024 | -22.27% | 0.00% | 0.00x | 1.14x | ILA-12.68 Million |
Industry Comparison
This section compares Allmed Solutions Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $45,740,556
- Average return on equity (ROE) among peers: -0.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Allmed Solutions Ltd (ALMD) | ILA35.08 Million | -44.58% | 0.07x | $96.61K |
| Erika Carmel Ltd (BCUR) | $8.97 Million | 138.94% | 4.32x | $46.92K |
| Bio-View Ltd (BIOV) | $23.45 Million | -5.34% | 0.48x | $54.59K |
| Erech Finance Cahalacha Ltd (EFNC) | $-63.00K | 0.00% | 0.00x | $19.28K |
| Endymed (ENDY) | $14.70 Million | 5.78% | 0.34x | $118.10K |
| Epitomee Medical Ltd (EPIT) | $34.80 Million | -16.33% | 0.16x | $567.43K |
| Human Xtensions Ltd (HUMX) | $61.78 Million | -72.18% | 0.17x | $21.16K |
| Ilex Medical (ILX) | $109.44 Million | 17.00% | 0.55x | $2.01 Million |
| Pulsenmore Ltd (PULS) | $132.23 Million | -44.29% | 0.36x | $321.83K |
| Sofwave Medical Ltd (SOFW) | $26.34 Million | -31.42% | 0.65x | $3.18 Million |